Discover our proprietary target and drug discovery platform streaMLine

We have longstanding experience leading large target and drug discovery programs with external partners in diabetes, obesity, NASH and other related diseases.

With our comprehensive databases containing hundreds of preclinical and clinical samples, our high-end NGS methodologies and team of uniquely skilled computational biologists, we provide a complete and remarkable platform from prediction, qualification and validatation of targets.